… of ARDS, and antiplatelet therapy may be a potential medication … We further summarize
antiplatelet therapy, including aspirin, … potential benefits of antiplatelet therapy for the prevention …

… distress syndrome (ARDS) is a life-threatening condition with high mortality that imposes a
serious medical burden. Antiplatelet therapy … to investigate whether antiplatelet therapy could …

… Our findings suggested antiplatelet therapy might show a protective effect on decreasing
the incidence rate of short-term mortality and ARDS/ALI. Accordingly, it may act as a …

… Dual antiplatelet therapy comprising aspirin plus a P2Y 12 inhibitor (clopidogrel, prasugrel,
or ticagrelor) is recommended for patients with NSTE-ACS, and those with STEMI both …

… assess the effect of antiplatelet therapy in critically ill patients. Antiplatelet therapy resulted in
… 027), incidence of respiratory distress syndrome or acute lung injury (RR 0.73, 95% CI, 0.58…

… Dual antiplatelet therapy (DAPT) combining aspirin and a … in patients with acute coronary
syndrome (ACS) with and … importance when choosing an appropriate antiplatelet therapy. …

… After adjusting for important confounding variables antiplatelet therapy was not … Antiplatelet
therapy was associated with a decreased incidence of acute respiratory distress syndrome/…

… Although the antiplatelet therapy had no effect on reducing the frequency of restenosis,
there was a large reduction in periprocedural Q-wave MI when antiplatelet therapy was started …

… and acute respiratory distress syndrome can also lead to … distinguish acute respiratory
distress syndrome without a histological … that this syndrome played a role in the present case. …

… . Early intravascular events are associated with development of acute respiratory distress
syndrome: a substudy of the LIPS-A clinical trial. Am J Respir Crit Care Med 2018;197(12):1575…